Membrane attack and therapy in autoimmune disease : modulating pathology whilst retaining physiology
I have created novel anti-complement reagents designed to deliver effective therapy locally, or where inhibition is long-term, to target only the terminal stages of complement. These agents have exciting potential to effectively treat complement-mediated diseases and to retain other crucial biologic...
| Main Author: | |
|---|---|
| Published: |
Cardiff University
2010
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.580383 |